Parenteral Packaging Market Size

  • Report ID: 3276
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Parenteral Packaging Market size was valued at USD 33.44 billion in 2024 and is set to exceed USD 70.46 billion by 2037, registering over 5.9% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of parenteral packaging is evaluated at USD 35.12 billion.

The growth of the market can be attributed to the rise in demand for parenteral drugs worldwide, followed by the increasing advancements in packaging materials, which provide the manufacturers of parenteral products a wide range of options to choose from for packaging their product. The demand for parenteral drugs is growing significantly, backed by the increasing developments of complex active pharmaceutical ingredients, new therapeutic approaches, and for the availability of numerous treatment options. Moreover, with the growing incidences of chronic diseases around the globe, there is a rise in demand for self-injection devices for treating various chronic diseases. Owing to the development of such products, there is a growing need amongst pharmaceutical manufacturers to choose from a wide range of packaging products which align to their needs. This, in turn, is anticipated to drive the parenteral packaging market growth in the coming years. According to the statistics by the United States Centers for Disease Control and Prevention (CDC), out of 10 adults in the U.S., 6 of them have a chronic disease. Moreover, out of 10 adults, 4 have two or more of the chronic diseases. 



Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of parenteral packaging is evaluated at USD 35.12 billion.

Parenteral Packaging Market size was valued at USD 33.44 billion in 2024 and is set to exceed USD 70.46 billion by 2037, registering over 5.9% CAGR during the forecast period i.e., between 2025-2037.

North America industry is estimated to dominate majority revenue share of 33% by 2037, North America industry is poised to account for largest revenue share of 33% by 2037

The major players in the market are UFP Technologies, Inc., SCHOTT AG, Gerresheimer AG, UDG Healthcare plc, West Pharmaceutical Services, Inc., SiO2 Medical Products Inc., and others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos